Livermore DM - Search Results

1

Discovery research: the scientific challenge of finding new antibiotics.

Livermore DM; British Society for Antimicrobial Chemotherapy Working Party on The Urgent Need: Regenerating Antibacterial Drug Discovery and Development. Livermore DM, et al. J Antimicrob Chemother. 2011 Sep;66(9):1941-4. doi: 10.1093/jac/dkr262. Epub 2011 Jun 23. J Antimicrob Chemother. 2011. PMID: 21700626

2

In vitro activity of cephalosporin RWJ-54428 (MC-02479) against multidrug-resistant gram-positive cocci.

Johnson AP, Warner M, Carter M, Livermore DM. Johnson AP, et al. Among authors: livermore dm. Antimicrob Agents Chemother. 2002 Feb;46(2):321-6. doi: 10.1128/AAC.46.2.321-326.2002. Antimicrob Agents Chemother. 2002. PMID: 11796337 Free PMC article.

3

Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).

Henwood CJ, Gatward T, Warner M, James D, Stockdale MW, Spence RP, Towner KJ, Livermore DM, Woodford N. Henwood CJ, et al. Among authors: livermore dm. J Antimicrob Chemother. 2002 Mar;49(3):479-87. doi: 10.1093/jac/49.3.479. J Antimicrob Chemother. 2002. PMID: 11864948

4

In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.

Johnson AP, Warner M, Livermore DM. Johnson AP, et al. Among authors: livermore dm. J Antimicrob Chemother. 2002 Jul;50(1):89-93. doi: 10.1093/jac/dkf068. J Antimicrob Chemother. 2002. PMID: 12096011

5

Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum beta-lactamases.

Babini GS, Yuan M, Hall LM, Livermore DM. Babini GS, et al. Among authors: livermore dm. J Antimicrob Chemother. 2003 Mar;51(3):605-12. doi: 10.1093/jac/dkg114. J Antimicrob Chemother. 2003. PMID: 12615861

6

Linezolid in vitro: mechanism and antibacterial spectrum.

Livermore DM. Livermore DM. J Antimicrob Chemother. 2003 May;51 Suppl 2:ii9-16. doi: 10.1093/jac/dkg249. J Antimicrob Chemother. 2003. PMID: 12730138 Review.

7

Properties and potential of ertapenem.

Livermore DM, Sefton AM, Scott GM. Livermore DM, et al. J Antimicrob Chemother. 2003 Sep;52(3):331-44. doi: 10.1093/jac/dkg375. Epub 2003 Aug 13. J Antimicrob Chemother. 2003. PMID: 12917243 Review.

8

Ciprofloxacin-resistant Escherichia coli from bacteraemias in England; increasingly prevalent and mostly from men.

Livermore DM, Nichols T, Lamagni TL, Potz N, Reynolds R, Duckworth G. Livermore DM, et al. J Antimicrob Chemother. 2003 Dec;52(6):1040-2. doi: 10.1093/jac/dkg479. Epub 2003 Oct 29. J Antimicrob Chemother. 2003. PMID: 14585850

9

Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized beta-lactamases.

Mushtaq S, Ge Y, Livermore DM. Mushtaq S, et al. Among authors: livermore dm. Antimicrob Agents Chemother. 2004 Apr;48(4):1313-9. doi: 10.1128/AAC.48.4.1313-1319.2004. Antimicrob Agents Chemother. 2004. PMID: 15047535 Free PMC article.

10

Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar.

Johnson AP, Mushtaq S, Warner M, Livermore DM. Johnson AP, et al. Among authors: livermore dm. J Antimicrob Chemother. 2004 May;53(5):860-2. doi: 10.1093/jac/dkh198. Epub 2004 Mar 31. J Antimicrob Chemother. 2004. PMID: 15056637

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

499 results

Search Page